Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imbruvica
Imbruvica
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
Thu, 12/6/18 - 07:01 pm
AbbVie
Imbruvica
CLL
JNJ
ASH 2018
Why Abbvie Is Down 5% in 2018 So Far
Motley Fool
Sat, 11/17/18 - 12:44 pm
AbbVie
Imbruvica
Humira
Orilissa
Excellent quarter from AbbVie, but market still skeptic about pipeline
GoinPharma
Sun, 11/4/18 - 02:50 pm
AbbVie
earnings
Imbruvica
AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring
Fierce Pharma
Fri, 10/19/18 - 11:13 pm
AbbVie
Abbott
Imbruvica
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
BioCentury
Wed, 10/17/18 - 12:24 pm
AbbVie
FDA
priority review
Imbruvica
Gazyva
CLL
SLL
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Yahoo/Motley Fool
Tue, 08/28/18 - 10:07 am
JNJ
Geron
hirings
imetelstat
Imbruvica
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
Mon, 08/27/18 - 10:02 am
AbbVie
JNJ
FDA
Imbruvica
Rituxan
Roche
AstraZeneca
non-Hodgkin's lymphoma
Waldenström’s macroglobulinemia
As Humira competition nears, AbbVie's Imbruvica and Mavyret pick up steam
Fierce Pharma
Fri, 07/27/18 - 07:05 pm
AbbVie
Humira
Imbruvica
Mavyret
ASCO18: AbbVie blood cancer combo off to a strong start in Phase 2
Biopharma Dive
Mon, 06/4/18 - 09:37 am
AbbVie
Imbruvica
Venclexta
chronic lymphocytic leukemia
small lymphocytic lymphoma
ASCO 2018
AbbVie eyes Imbruvica expansion in CLL as Gazyva pairing hits its marks
Fierce Pharma
Thu, 05/24/18 - 05:44 pm
AbbVie
Imbruvica
CLL
Gazyva
AbbVie bows to pressure to keep cheaper Imbruvica formula on the market
Fierce Pharma
Wed, 05/16/18 - 06:57 pm
AbbVie
Imbruvica
Here's How AbbVie Inc. Crushed It in 2017
Yahoo/Motley Fool
Tue, 12/26/17 - 09:48 am
AbbVie
biosimilars
Humira
Imbruvica
7 Things AbbVie's Top Executives Just Said That You'll Want to Know
Motley Fool
Fri, 11/10/17 - 10:19 am
AbbVie
Humira
Imbruvica
Venclexta
Amazon
tax reform
There's a Lot to Like in AbbVie's Q3 Update
Motley Fool
Fri, 10/27/17 - 02:44 pm
AbbVie
earnings
Humira
Imbruvica
Mavyret
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
Sun, 09/17/17 - 09:56 am
JNJ
Remicade
Stelara
drug pricing
Imbruvica
Xarelto
Darzalex
devices
consumer health
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Motley Fool
Sat, 08/5/17 - 09:43 am
JNJ
devices
baby boomers
specialty medicines
M&A
Genmab
Imbruvica
J&J, AbbVie's Imbruvica breaks out of blood-cancer corner with new graft-versus-host approval
Fierce Pharma
Wed, 08/2/17 - 09:33 pm
JNJ
AbbVie
Imbruvica
graft vs host disease
FDA
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
AbbVie Is Focused on Label Expansion of Imbruvica in 2017
Market Realist
Tue, 05/2/17 - 11:22 am
AbbVie
Imbruvica
non-Hodgkin's lymphoma
mantle cell lymphoma
graft vs host disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »